Polyphenols and their nanoformulations as potential antibiofilm agents against multidrug-resistant pathogens

Modawy Em Elkhalifa1,2, Muhammad Ashraf3, Alshebli Ahmed1,2

  • 1Public Health Department, Health Sciences College at Al-Leith, Umm Al-Qura University, Al leith, KSA.

Future Microbiology
|February 2, 2024
PubMed

Insights

Polyphenolics combat biofilms, a major challenge in treating multidrug-resistant (MDR) infections. Nanoformulations enhance these compounds

Area of Science:

  • Microbiology
  • Pharmacology
  • Materials Science

Background:

  • Multidrug-resistant (MDR) pathogens pose a significant threat to infectious disease treatment.
  • Bacterial biofilms, a matrix of proteins and polysaccharides, contribute to antimicrobial resistance.
  • Polyphenolics show promise in combating bacterial infections and biofilms.

Purpose of the Study:

  • To review the antibiofilm activity of polyphenolics.
  • To elucidate the mechanisms by which polyphenolics exert their antibiofilm effects.
  • To explore the potential of nanoformulations in enhancing polyphenolic efficacy against biofilms.

Main Methods:

  • Literature review of studies on polyphenolics and biofilms.
  • Analysis of reported mechanisms of antibiofilm action.
  • Evaluation of nanoformulation strategies for polyphenolics.

Main Results:

  • Polyphenolics disrupt bacterial membranes, inhibit adhesion, and interfere with biofilm formation.
  • Limitations of polyphenolics include poor solubility, bioavailability, and stability.
  • Nanoformulations can overcome these limitations, enhancing antibacterial and antibiofilm potential.

Conclusions:

  • Polyphenolics are effective antibiofilm agents with diverse mechanisms.
  • Nanoformulation is a viable strategy to improve polyphenolic delivery and efficacy.
  • Polyphenolics, especially when nanoformulated, show potential as resistance-modifying agents against MDR pathogens.